NCT00486954 - Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer | Biotech Hunter

Enrollment

273

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2012

Study Completion Date

October 31, 2012

Conditions

Neoplasms, Gastrointestinal Tract

Interventions

DRUG

Lapatinib

6 pills at 250 mg each once daily

DRUG

Paclitaxel

Infusion at 80 mg/m2 weekly

Trial Locations (17)

100

GSK Investigational Site, Taipei

112

GSK Investigational Site, Taipei

333

GSK Investigational Site, Tau-Yuan County

704

GSK Investigational Site, Tainan City

736

GSK Investigational Site, Tainan County

807

GSK Investigational Site, Kaohsiung City

833

GSK Investigational Site, Niaosong Township, Kaohsiung

100021

GSK Investigational Site, Beijing

100071

GSK Investigational Site, Beijing

200032

GSK Investigational Site, Shanghai

510060

GSK Investigational Site, Guangzhou

113-8677

GSK Investigational Site, Tokyo

519-809

GSK Investigational Site, Hwasun

463-707

GSK Investigational Site, Seongnam-si Gyeonggi-do

110-744

GSK Investigational Site, Seoul

120-752

GSK Investigational Site, Seoul

135-710

GSK Investigational Site, Seoul